CONMED Profit Margin 2006-2018 | CNMD

Current and historical gross, operating and net profit margin for CONMED (CNMD) over the last 10 years. The current net profit margin for CONMED as of June 30, 2018 is 8.85%.
CONMED Annual Profit Margin Summary
CONMED Quarterly Profit Margin Summary
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.185B $0.796B
CONMED Corporation is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. The Company distributes its products worldwide from several manufacturing locations.
Stock Name Country Market Cap PE Ratio
Becton, Dickinson (BDX) United States $67.726B 24.25
Align Technology (ALGN) United States $28.698B 76.51
McKesson (MCK) United States $25.846B 9.89
AmerisourceBergen (ABC) United States $18.979B 13.79
Laboratory Of America Holdings (LH) United States $18.565B 17.07
Cardinal Health (CAH) United States $16.125B 10.81
Cooper (COO) United States $12.651B 23.55
Henry Schein (HSIC) United States $12.301B 20.98
DENTSPLY SIRONA (XRAY) United States $8.598B 15.05
West Pharmaceutical Services (WST) United States $8.532B 44.11
Merit Medical Systems (MMSI) United States $3.101B 40.76
Patterson (PDCO) United States $2.237B 14.01
STAAR Surgical (STAA) United States $1.804B 241.47
Atrion (ATRI) United States $1.213B 35.96
Antares Pharma (ATRS) United States $0.534B 0.00
Invacare (IVC) United States $0.525B 0.00
Endologix (ELGX) United States $0.215B 0.00
Lifevantage (LFVN) United States $0.163B 23.08
Aceto (ACET) United States $0.100B 4.07
Biolase (BIOL) United States $0.037B 0.00
Pro-Dex (PDEX) United States $0.029B 12.69
Milestone Scientific (MLSS) United States $0.025B 0.00
Retractable Technologies (RVP) United States $0.024B 0.00